danthron has been researched along with Cancer of Pancreas in 1 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H | 1 |
| Zhao, C | 1 |
| He, R | 1 |
| Zhou, M | 1 |
| Liu, Y | 1 |
| Guo, X | 1 |
| Wang, M | 1 |
| Zhu, F | 1 |
| Qin, R | 1 |
| Li, X | 1 |
1 other study available for danthron and Cancer of Pancreas
| Article | Year |
|---|---|
Danthron suppresses autophagy and sensitizes pancreatic cancer cells to doxorubicin.
Topics: Anthraquinones; Antibiotics, Antineoplastic; Autophagy; Cell Line, Tumor; Doxorubicin; Drug Synergis | 2019 |